Otis W. Brawley, MD, chief medical officer of the American Cancer Society (ACS), visited Hollings Cancer Center recently to discuss the future of cancer. Dr. Brawley’s visit coincided with an announcement that Hollings will receive a $450,000 grant from the ACS supporting research. 

This grant program supports new projects undertaken by junior faculty. Past recipients of these grants have gone on to make important discoveries in cancer research and treatment around the world.

 “By supporting our young researchers now, we are investing in the next generation of investigators who have the potential will make important strides in the fight against cancer,” said Andrew S. Kraft, MD, director of Hollings Cancer Center. “It’s important to remember that some of the best drugs have been developed by researchers who got their start with American Cancer Society funding. “We are so appreciative of our relationship with a world leader in fighting cancer.” 

Brawley addressed physicians and researchers at Hollings about the future of cancer. 

 “Medical research and especially cancer research is in crisis,” said Otis W. Brawley, M.D., chief medical officer of the American Cancer Society. “As funding and support is drying up, it becomes much less attractive to our best and brightest. We’re extremely grateful for the public’s continued support that allows us to support these researchers whose work will benefit us all.” 

In March, Hollings was awarded designation from the National Cancer Institute (NCI), a distinction shared by just 65 cancer centers in the U.S. Hollings is the only NCI center in South Carolina.